BRAND: Padviram 600 mg/200 mg/245 mg film-coated tablets
ACTIVE INGREDIENT: efavirenz/emtricitabine/tenofovir disoproxil
STRENGTH, PACK SIZE:
Padviram is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. It is indicated for the treatment of human immunodeficiency virus-I (HIV-1) infection in adults aged 18 years and over with virologic suppression to HIV-I RNA levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months.
For more detailed information, please see SPC.